| scholarly article | Q13442814 |
| P50 | author | Gregg L. Semenza | Q1545025 |
| P2093 | author name string | Tao Ma | |
| Harsh Patel | |||
| Akrit Sodhi | |||
| Silvia Montaner | |||
| Savalan Babapoor-Farrokhran | |||
| Renty Franklin | |||
| P2860 | cites work | Kaposi's sarcoma and its associated herpesvirus | Q36487309 |
| Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity | Q37058091 | ||
| The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene | Q37070142 | ||
| Metabolic pathway alterations that support cell proliferation. | Q37977398 | ||
| Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer | Q38012878 | ||
| Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. | Q38021339 | ||
| Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells. | Q38052531 | ||
| The multifaceted regulation and functions of PKM2 in tumor progression | Q38234285 | ||
| Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression | Q40002571 | ||
| A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia | Q40106826 | ||
| HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity | Q40136909 | ||
| The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor | Q40244438 | ||
| Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I. | Q40245270 | ||
| The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. | Q40333151 | ||
| Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression | Q40537413 | ||
| The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha | Q42796220 | ||
| Real‐Time Quantitative PCR Analysis of Mitochondrial DNA Content | Q54392675 | ||
| Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes | Q78860218 | ||
| Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 | Q24304533 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| HIF-1: upstream and downstream of cancer metabolism | Q24647482 | ||
| Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis | Q27671695 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| Pyruvate kinase type M2 and its role in tumor growth and spreading | Q28252131 | ||
| Molecular virology of Kaposi's sarcoma-associated herpesvirus | Q28363323 | ||
| The biology of cancer: metabolic reprogramming fuels cell growth and proliferation | Q29547301 | ||
| The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth | Q29547680 | ||
| Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics | Q29615944 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma | Q33895137 | ||
| Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells | Q33934809 | ||
| Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma | Q34069841 | ||
| Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells | Q34257830 | ||
| Regulation of mTORC1 and its impact on gene expression at a glance | Q34342717 | ||
| Evidence for an alternative glycolytic pathway in rapidly proliferating cells | Q34535762 | ||
| Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors | Q35139228 | ||
| Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induction by Hypoxia and Hypoxia-Inducible Factors | Q35665756 | ||
| Quantitative Assessment of Angiogenic Responses by the Directed in Vivo Angiogenesis Assay | Q35749086 | ||
| Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study | Q35827892 | ||
| Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers | Q35895560 | ||
| Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy | Q36220497 | ||
| Emerging roles of PKM2 in cell metabolism and cancer progression | Q36303571 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 477-488 | |
| P577 | publication date | 2015-06-20 | |
| P1433 | published in | Angiogenesis | Q15753544 |
| P1476 | title | KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma | |
| P478 | volume | 18 |
| Q91757226 | A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency |
| Q39426973 | Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers |
| Q38902275 | Activation of cellular metabolism during latent Kaposi's Sarcoma herpesvirus infection |
| Q39137289 | Central Role of Metabolism in Endothelial Cell Function and Vascular Disease |
| Q91107161 | Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice |
| Q36167973 | Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway. |
| Q40301190 | Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication |
| Q38610039 | Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs |
| Q38802773 | Hijacking GPCRs by viral pathogens and tumor |
| Q39414795 | Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells. |
| Q60309517 | Hypoxia-Inducible Factor 1-α (HIF-1α) Induces Apoptosis of Human Uterosacral Ligament Fibroblasts Through the Death Receptor and Mitochondrial Pathways |
| Q42366342 | Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma. |
| Q92340148 | In Vivo Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus |
| Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
| Q47606321 | Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology |
| Q91397053 | Kaposi's sarcoma-associated herpesvirus is cell-intrinsically controlled in latency in microgravity |
| Q94545914 | Lack of CD8+ T-cell co-localization with Kaposi's sarcoma-associated herpesvirus infected cells in Kaposi's sarcoma tumors |
| Q53781024 | Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q59350363 | Oncogenic KSHV Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, to Activate the STAT3 Pathway and Promote Growth Transformation |
| Q58555606 | Oncogenic virus-induced aerobic glycolysis and tumorigenesis |
| Q39374497 | Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma |
| Q92649728 | Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment |
| Q54123249 | Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1α-dependent glycolysis. |
| Q92382681 | REDD1 overexpression in oral squamous cell carcinoma may predict poor prognosis and correlates with high microvessel density |
| Q36238539 | RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature. |
| Q39284842 | Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update |
| Q45419184 | The Glycolytic Switch in Tumors: How Many Players Are Involved? |
| Q47637704 | The control of oligodendrocyte bioenergetics by interferon-gamma (IFN-γ) and Src homology region 2 domain-containing phosphatase-1 (SHP-1). |
| Q39329214 | The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis. |
| Q26766079 | The sweet trap in tumors: aerobic glycolysis and potential targets for therapy |
| Q66679091 | Viral hijacking of cellular metabolism |
Search more.